Amyris Inc (NASDAQ:AMRS) shares fell 20.1% during trading on Wednesday . The stock traded as low as $2.97 and last traded at $3.10. 6,496,075 shares changed hands during mid-day trading, an increase of 114% from the average session volume of 3,029,759 shares. The stock had previously closed at $3.88.

Several research firms have recently commented on AMRS. HC Wainwright set a $11.00 price objective on shares of Amyris and gave the company a “buy” rating in a research note on Tuesday, February 5th. BidaskClub raised shares of Amyris from a “strong sell” rating to a “sell” rating in a research note on Tuesday, November 27th. Finally, Zacks Investment Research lowered shares of Amyris from a “hold” rating to a “sell” rating in a research note on Thursday, January 3rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $8.83.

The company has a market cap of $296.94 million, a P/E ratio of -1.23 and a beta of 0.39.

Amyris (NASDAQ:AMRS) last issued its quarterly earnings results on Monday, March 18th. The biotechnology company reported ($1.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($1.51). The company had revenue of $19.36 million for the quarter, compared to the consensus estimate of $98.52 million. During the same period in the prior year, the company earned $0.61 EPS. The firm’s revenue was down 76.0% compared to the same quarter last year.

Institutional investors have recently modified their holdings of the stock. Jane Street Group LLC purchased a new position in Amyris in the fourth quarter worth approximately $48,000. Caption Management LLC purchased a new position in Amyris in the fourth quarter worth approximately $50,000. HRT Financial LLC purchased a new position in Amyris in the fourth quarter worth approximately $52,000. Dynamic Technology Lab Private Ltd purchased a new position in Amyris in the third quarter worth approximately $127,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Amyris in the fourth quarter worth approximately $58,000. Institutional investors own 36.69% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Amyris (AMRS) Stock Price Down 20.1%” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2019/03/20/amyris-amrs-stock-price-down-20-1.html.

About Amyris (NASDAQ:AMRS)

Amyris, Inc, an integrated renewable products company, delivers alternatives to petroleum, plant, and animal-based products across a range of consumer and industry segments worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients, and consumer products.

Read More: NASDAQ Stock Market Explained

Receive News & Ratings for Amyris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris and related companies with MarketBeat.com's FREE daily email newsletter.